Should the FDA regulate pharmacoeconomic studies?
Robinson
M
M
D003362:Cost-Benefit Analysis; D004341:Drug Evaluation / Q000191:economics* / Q000331:legislation & jurisprudence / Q000592:standards; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D006801:Humans; D008329:Managed Care Programs / Q000592:standards*; D014481:United States; D014486:United States Food and Drug Administration